0001962036-23-000001.txt : 20230113 0001962036-23-000001.hdr.sgml : 20230113 20230113135000 ACCESSION NUMBER: 0001962036-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230113 DATE AS OF CHANGE: 20230113 EFFECTIVENESS DATE: 20230113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Perceive Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001962036 IRS NUMBER: 844344959 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-470703 FILM NUMBER: 23528294 BUSINESS ADDRESS: STREET 1: 6000 SHORELINE DRIVE, SUITE 206 STREET 2: ATTN: CEO CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 707-477-8172 MAIL ADDRESS: STREET 1: 6000 SHORELINE DRIVE, SUITE 206 STREET 2: ATTN: CEO CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 D 1 primary_doc.xml X0708 D LIVE 0001962036 Perceive Biotherapeutics, Inc. 6000 SHORELINE DRIVE, SUITE 206 ATTN: CEO SOUTH SAN FRANCISCO CA CALIFORNIA 94080 707-477-8172 DELAWARE Oriole Therapeutics, Inc. None Corporation true 2020 Kirsten Angela Macfarlane 6000 Shoreline Drive, Suite 206 South San Francisco CA CALIFORNIA 94080 Executive Officer Director Promoter Anne Rubin 6000 Shoreline Drive, Suite 206 South San Francisco CA CALIFORNIA 94080 Executive Officer Director Robert Jackson 6000 Shoreline Drive, Suite 206 South San Francisco CA CALIFORNIA 94080 Director Cameron Wheeler 6000 Shoreline Drive, Suite 206 South San Francisco CA CALIFORNIA 94080 Director Randall Olson 6000 Shoreline Drive, Suite 206 South San Francisco CA CALIFORNIA 94080 Director Watson Debi 6000 Shoreline Drive, Suite 206 South San Francisco CA CALIFORNIA 94080 Director Biotechnology Decline to Disclose 06b false 2022-12-29 false true false 0 77999974 39999986 37999988 false 6 0 0 0 false Perceive Biotherapeutics, Inc. /s/ Kirsten Angela Macfarlane Kirsten Angela Macfarlane CEO 2023-01-12